Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient
|
|
- Theodora Evans
- 7 years ago
- Views:
Transcription
1 Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient Kim Spelts, CVT, VTS (Anesthesia), CCRP, CCMT Peak Performance Veterinary Group No anesthetic procedure is entirely safe, but critically ill patients present a much higher level of risk and likelihood of perianesthetic complications. Awareness and anticipation of drug side effects as well as physiologic complications associated with various pathologies will help reduce the risk of and improve the likelihood of a favorable outcome. The selection of drugs for all phases of anesthesia (premedication, induction, and maintenance) must include an analysis of the risk-to-benefit ratio. In critically ill patients the side effects of anesthetic drugs may be greater than what would be seen in a normal, healthy patient. There are no perfect drugs, and only a safe anesthetist can reduce the impact of any drug s negative side effects. All anesthetic agents can significantly alter cardiac output. One must consider the effects of chosen drugs on the formula CO = HR x SV, where CO = cardiac output, HR = heart rate, and SV = stroke volume (a function of preload, afterload, and contractility). The goal with any anesthetic procedure should be balanced anesthesia: providing adequate hypnosis, amnesia, analgesia, and muscle relaxation. Rather than using a few drugs, balanced anesthesia is best achieved with lower doses of multiple drugs. This is an especially important concept when anesthetizing critical patients as a way to help minimize potential side effects associated with higher drug doses. Proper patient assessment prior to anesthesia is crucial when developing an anesthetic plan. One should of course consider the patient s underlying health status, such as age and concurrent chronic disease (cardiovascular, renal, hepatic, endocrine). What is the patient s status upon presentation? What is his or her mentation (alert, depressed, obtunded, moribund)? Is the patient painful? Are there any bloodwork abnormalities? Most importantly for our critical patients, what is the cardiovascular status? Is the patient hemorrhaging? In shock? Have any fluids or pain medications been administered? Is the patient responding to stabilizing measures? One must also anticipate complications such as hypotension, cardiac dysrhythmias, and hemorrhage, which vary from procedure to procedure. Premedication Premedication of any patient will allow lower doses of induction and maintenance agents to be used. Premedication can also provide preemptive analgesia. It is important to remember, however, that critically ill patients will require lower than normal doses of premeds, and for those patients who are most compromised, premedication may be contraindicated.
2 Acepromazine is a tranquilizer and anxiolytic agent that is commonly used in healthy patients. It has antidysrhythmic effects and can reduce afterload, which may make it an appropriate drug for use in some compromised patients (such as those with mitral regurgitation or a left-right shunt). It should be avoided in patients with ventricular hypertrophy, coagulopathy, seizures, or shock. Alpha-2 agonists such as dexmedetomidine and xylazine have profound effects on cardiac output (via a decrease in heart rate and increase in afterload) and their use should generally be avoided in critically ill patients. Extremely low doses of dexmedetomidine (0.5-1 mcg/kg) may be utilized in the postoperative period to provide analgesia and anxiolysis. Dexmedetomidine is reversible with atipamazole (0.1 mg/kg IV or IM), but IV administration of atipamazole during the use of inhalant anesthetics should be avoided due to the risk of unresuscitatable cardiac arrest. Benzodiazepines such as midazolam and diazepam have minimal cardiovascular effects. Alone, they often cause excitement, but combined with an opioid can result in sedation. Because it is water soluble, midazolam is preferred over diazepam when administered IM or SQ, or when combined in the same syringe with other drugs. Benzodiazepines are reversible with flumazenil (0.01 mg/kg IV). The use of anticholinergics should be considered if opioids are used as a concurrent premedication and/or as an induction agent. Glycopyrrolate (0.01 mg/kg SQ/IM, mg/kg IV) and atropine ( mg/kg SQ/IM, 0.01 mg/kg IV) both help maintain cardiac output by maintaining or increasing heart rate in the presence of opioid-induced bradycardia. Opioids provide both sedation and analgesia. Patients occasionally become dysphoric with their use, so a concurrent tranquilizer or sedative may be required. Opioids have minimal cardiovascular effects, the most common being bradycardia. As a result, a concurrent or subsequent dose of an anticholinergic may be required. Pure mu agonists (morphine, fentanyl, hydromorphone, oxymorphone, methadone, and remifentanil) provide the best analgesia. Methadone has the added benefit of acting as an NMDA receptor antagonist. Mu agonists can be completely reversed with naloxone (10 mcg/kg, usually given 1/2 IV and 1/2 SQ) and partially reversed with nalbuphine (0.5 mg/kg IV). Induction The induction phase of anesthesia is one of the most dangerous, especially for critical patients. While the effects of most induction drugs are transient, they are significant enough to potentially push a compromised patient close to cardiovascular collapse. All induction agents cause some degree of respiratory and cardiovascular depression. Propofol is a rapid-onset, ultra-short-acting injectable anesthetic. Its effects are noncumulative, and recovery is generally rapid and smooth. It can be administered as intermittent boluses or as a constant rate infusion (10-20 mg/kg/hr), with or without concurrent opioids, to reduce or replace inhalant anesthetic. Propofol causes a decrease in contractility, can predispose the heart to ventricular dysrhythmias, and can cause splenic engorgement. Propofol can also have significant vasodilatory effects. Its negative effects are dose-dependent. The required dose of propofol can be reduced by a slower administration and/or the concurrent administration of an IV benzodiazepine. An average
3 induction dose of propofol is 4-8 mg/kg in sicker patients, but this can be reduced to 2-4 mg/kg with concurrent benzodiazepine use. Propofol is an appropriate induction drug for generally healthy or mildly compromised patients, but it should be avoided or used with extreme caution in patients suffering from anemia, hypovolemia, sepsis, or shock. Opioids, such as fentanyl (5-10 mcg/kg IV) or hydromorphone ( mg/kg IV) do not provide true induction of anesthesia; rather, they result in sedation heavy enough to allow endotracheal intubation. Induction can be lengthy, and intubation can be difficult (especially in alert patients). While preoxygenation is always recommended prior to induction of anesthesia, it is especially crucial when inducing with opioids due to the significant respiratory depression that occurs. Concurrent use of a benzodiazepine can provide a smoother induction and additional muscle relaxation. Opioid inductions are generally not smooth in cats. Opioids have minimal effects on contractility, but they can cause a decrease in heart rate that may be significant enough to cause a decrease in cardiac output. Consequently, an anticholinergic should be used to help the patient maintain at least a high-normal heart rate. This is especially true in severely compromised patients (endotoxemia, shock, hypovolemia) who require a high heart rate to maintain their cardiac output. Opioid inductions are appropriate in sick, compromised patients. Of all the induction drugs available, etomidate has the fewest cardiovascular and respiratory effects. It comes in a propylene glycol base, and due to the hyperosmolarity of this solution it can cause acute hemolysis at the injection site. It is recommended that the drug be administered through a fluid line and/or diluted 1:1 with sterile saline when administered to small patients. Significant myoclonus can occur, but this risk is reduced if an adequate premedication is administered or if a concurrent benzodiazepine is used. Etomidate can also cause transient adrenocortical suppression, so it should be used with caution in Addisonian patients. While etomidate has the fewest respiratory and cardiovascular effects of all the induction drugs available, it is also the most expensive. An average induction dose is 1-2 mg/kg IV, but this dose can be reduced to mg/kg with concurrent administration of a benzodiazepine and opioid. Concurrent use of benzodiazepines (midazolam or diazepam, mg/kg IV) can reduce the amount of primary induction drug required, thereby minimizing the negative side effects of the primary induction drug. Benzodiazepines provide excellent muscle relaxation as well as amnesia. They can be administered intraoperatively as intermittent boluses or as a constant rate infusion of 0.1 mg/kg/hr. Diazepam has the potential to precipitate when mixed with other drugs, so care must be taken to avoid this (do not mix in same syringe with other drugs; do not administer through a line containing other drugs, etc.). Ketamine is a popular induction drug in veterinary medicine. Due to its increase in sympathetic stimulation, its use should be avoided in critically ill patients (who may already be maximally sympathetically stimulated). Ketamine also has dangerous side effects in cats that have not been adequately explained, such as acute blindness and sudden death. Ketamine s primary uses should be limited to the induction of young, healthy dogs, and as a microinfusion (2-10 mcg/kg/min) for its NMDA receptor antagonist effects.
4 Maintenance Balanced anesthesia should continue during the maintenance phase of anesthesia. Loss of consciousness, awareness, and memory may be provided with inhalant anesthetics, a propofol infusion, and/or an infusion or intermittent boluses of benzodiazepines. Analgesia can be provided by infusions or boluses of opioids or lidocaine, and by performing local anesthetic procedures (such as an incisional line block). An NMDA receptor antagonist such as ketamine can be administered as a microinfusion to prevent central neuronal hypersensitivity ( wind-up ). Immobilization of the patient may be achieved with the use of inhalants, a propofol infusion, or the administration of a neuromuscular blocking agent such as atracurium. For critical patients, isoflurane, sevoflurane, or desflurane are the anesthetic inhalants of choice. They each share and can be compared by the following properties: Potency, which is described by an agent s mean alveolar concentration (MAC, the concentration at which 50% of patients will respond to a noxious stimulus, or ED 50 ). In humans, ED 95 (the dose at which 95% of patients are anesthetized) is 20-40% greater than MAC. Blood:gas solubility coefficient, which describes the rate of change in the agent s concentration in the blood. The lower the solubility, the faster the change in alveolar concentration, and the faster the change in anesthetic plane. Atracurium is a valuable adjunct to the maintenance of anesthesia in critically ill patients. Some patients are so sensitive to the negative effects of inhalant anesthesia (especially the decrease in cardiac contractility) that it becomes necessary to paralyze the patient and keep the inhalant at a very low setting (less than 0.5%) or turned off completely. Atracurium is a non-depolarizing neuromuscular blocking agent that competes with acetylcholine to produce systemic muscle relaxation (paralysis). The administration of atracurium REQUIRES the use of intermittent positive pressure ventilation, preferably mechanical rather than manual. It is also recommended to apply a peripheral nerve stimulator to the patient to evaluate train of 4 twitches as a method of assessing the effect and clearance of atracurium. If a nerve stimulator is not available, the anesthetist should watch closely for signs of voluntary movement and spontaneous ventilation. The duration of action is highly ph- and temperature-dependent, so care must be taken to manage both of these parameters during the perianesthetic period. Dosing of atracurium is 0.2 mg/kg for the first dose, then 0.1 mg/kg thereafter. It is not recommended to dose more frequently than every minutes in critical patients unless (a) a peripheral nerve stimulator is applied, or (b) voluntary movement is observed. Atracurium can be reversed with neostigmine ( mg/kg IV) or edrophonium (0.5 mg/kg IV), but since the duration of action may be longer than the duration of either of these reversal agents, the potential for reparalysis exists. Careful monitoring in the postanesthetic period is crucial. If the inhalant is turned off completely, administer intermittent boluses of midazolam (0.1 mg/kg IV) or place the patient on a midazolam infusion (0.1 mg/kg/hr) to provide amnesia during the perianesthetic period. Summary Critical patients have a high risk of experiencing potentially life-threatening anesthetic complications. One can help minimize the anesthetic risk by being aware of the physiologic effects of all anesthetic
5 drugs administered and anticipating, monitoring, and rapidly responding to changes in the status of the patient. References/Suggested Reading Muir W, Hubbell J. Handbook of Veterinary Anesthesia. 3 rd ed. St. Louis: Mosby, Inc., Thurmon J, Tranquilli W, Benson GJ. Essentials of Small Animal Anesthesia & Analgesia. Baltimore: Lippincott Williams & Wilkins, 1999.
HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida
HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida Management of severe pain in small animals continues to be a challenge
More informationFeline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia
Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia Chemical Restraint Protocols Trap, Neuter, Release Anesthetic
More informationIACUC Guideline LARGE ANIMAL FORMULARY
The intention behind the development of a University of Pennsylvania IACUC-endorsed drug formulary for the larger species used in biomedical research was to provide guidance for anesthetic and analgesic
More informationANESTHETIC AGENTS PRE-ANESTHETICS AND ANALGESICS
ANESTHETIC AGENTS The following provides a very brief overview of the anesthetic agents most commonly used in HSVMA- RAVS small animal protocols. This is NOT a detailed monograph on the listed drugs. Consult
More informationPROCEDURAL SEDATION/ANALGESIA NCBON Position Statement for RN Practice
PROCEDURAL SEDATION/ANALGESIA NCBON Position Statement for RN Practice P.O. BOX 2129 Raleigh, NC 27602 (919) 782-3211 FAX (919) 781-9461 Nurse Aide II Registry (919) 782-7499 www.ncbon.com Issue: Administration
More informationPassionate concerns about welfare and ethics have created an environment where discussions about
M e d i c a t i o n s P A I N M A N A G E M E N T Lysa Pam Posner, DVM, Diplomate ACVA North Carolina State University Analgesia for Declaw Patients Onychectomy in cats is controversial both within and
More informationTargeting patients for use of dexmedetomidine
Targeting patients for use of dexmedetomidine H a n n a h W u n s c h, M D M S c H e r b e r t I r v i n g A s s i s t a n t P r o f e s s o r o f A n e s t h e s i o l o g y & E p i d e m i o l o g y
More informationEquine Sedation, Anesthesia and Analgesia
Equine Sedation, Anesthesia and Analgesia Janyce Seahorn, DACVAA, DACVIM-LA, DACVECC Lexington Equine Surgery and Sports Medicine Equine Veterinary Specialists Georgetown, KY The need for equine field
More information*Reflex withdrawal from a painful stimulus is NOT considered a purposeful response.
Analgesia and Moderate Sedation This Nebraska Board of Nursing advisory opinion is issued in accordance with Nebraska Revised Statute (NRS) 71-1,132.11(2). As such, this advisory opinion is for informational
More informationObjectives. Important Principles
Management of the Intubated Patient Christopher J. Edwards, PharmD, BCPS Clinical Pharmacist - Emergency Medicine March 19 th, 2013 REPS EC SAG 2 Objectives Describe the rationale for post intubation analgesia
More informationWITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
More informationPatient Care Services Policy & Procedure Title: No. 8720-0059
Page: 1 of 8 I. SCOPE: This policy applies to Saint Francis Hospital, its employees, medical staff, contractors, patients and visitors regardless of service location or category of patient. This policy
More informationABSTRACT: The purpose of this article is to introduce readers to a brief overview of the
Demystifying Anesthesia By William E. Feeman III, DVM ABSTRACT: The purpose of this article is to introduce readers to a brief overview of the process of anesthesia and the various options available. A
More informationDrugs & Everything Else
Pain Relief, Common Drugs & Everything Else Henrik Jörnvall MD, PhD MKAIC November 11 2011 Lidocaine Noradrenaline Isoflurane Morphine Ropivacaine Platelets l t Pethidine Dobutamine Propofol Normal Saline
More informationIACUC Guideline RODENT ANESTHESIA & ANALGESIA FORMULARY
Background This guideline is designed to provide a single source of information for investigators that use rodents models of biomedical disease and discovery. The following tables reference contemporary
More informationUnderstanding Your Clinic s Recipes: High Volume Anesthesia and Analgesia
Understanding Your Clinic s Recipes: High Volume Anesthesia and Analgesia Emily McCobb DVM MS DACVAA Director, Tufts Shelter Medicine Program Assistant Director, Center for Animals and Public Policy Cummings
More informationEMS Branch / Office of the Medical Director. Active Seziures (d) Yes Yes Yes Yes. Yes Yes No No. Agitation (f) No Yes Yes No.
M07 Medications 2015-07-15 All ages EMS Branch / Office of the Medical Director Benzodiazepines Primary Intermediate Advanced Critical INDICATIONS Diazepam (c) Lorazepam (c) Midazolam (c) Intranasal Midazolam
More informationDRAFT 7/17/07. Procedural Sedation and Rapid Sequence Intubation (RSI) Consensus Statement
Procedural Sedation and Rapid Sequence Intubation (RSI) Consensus Statement Many patients with emergency medical conditions in emergency and critical care settings frequently experience treatable pain,
More informationCANINE & FELINE ANESTHESIA
Canine Anesthesia Introduction CANINE & FELINE ANESTHESIA Lyon Lee DVM PhD DACVA A general anesthetic to a healthy dog should bear little risk to the animal s life. However, although the mortality rate
More informationPAIN MANAGEMENT Alison Deputy, LVT
VCA Veterinary Specialty Center of Seattle Continuing Education Seminar 2011 PAIN MANAGEMENT Alison Deputy, LVT The process in which the brain receives, interprets and reacts to pain is extremely complicated
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Buprenovet 0.3 mg/ml Solution for Injection for Dogs and Cats (AT, DE)
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats (UK, BE, FR, IE, LU, NL, ES) Buprenovet 0.3 mg/ml Solution for
More informationPharmacology of Procedural Sedation
AACN Advanced Critical Care Volume 23, Number 4, pp.349 354 2012, AACN ECG Challenges Earnest Alexander, PharmD, and Gregory M. Susla, PharmD Department Editors Pharmacology of Procedural Sedation Danyel
More informationMedical Coverage Policy Monitored Anesthesia Care (MAC)
Medical Coverage Policy Monitored Anesthesia Care (MAC) Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2004 Policy Last Updated: 1/8/2013 Prospective review is recommended/required.
More information7. We often use Marcaine in tonsillectomies for longer acting analgesia. What is the dose? What are the particular side effects?
7. We often use Marcaine in tonsillectomies for longer acting analgesia. What is the dose? What are the particular side effects? Marcaine dosing per uptodate is Local anesthesia: Infiltration: 0.25% infiltrated
More informationANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
More informationPain Relief & Common Drugs. Henrik Jörnvall MD, PhD
Pain Relief & Common Drugs Henrik Jörnvall MD, PhD MKAIC May 5 2010 Pain Definition An unpleasant sensory and emotional experience assocated with actual or potential tissue damage or described in terms
More information9/16/2010. Contact Information. Objectives. Analgesic Ketamine (Ketalar )
Analgesic Ketamine (Ketalar )..the long and winding road to clinical practice Contact Information Lois Pizzi BSN, RN-BC Inpatient Pain Management Clinician UPMC Presbyterian Shadyside pizzilj@upmc.edu
More informationPHSW Procedural Sedation Post-Test Answer Key. For the following questions, circle the letter of the correct answer(s) or the word true or false.
PHSW Procedural Sedation Post-Test Answer Key 1 1. Define Procedural (Conscious) Sedation: A medically controlled state of depressed consciousness where the patient retains the ability to continuously
More information!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationNaloxone Hydrochloride Injection PRODUCT INFORMATION
Naloxone Hydrochloride Injection PRODUCT INFORMATION DESCRIPTION Naloxone hydrochloride is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; C 19 H 21 NO 4.HCl. It is an off-white powder
More informationCommon Surgical Procedures in the Elderly
Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of
More informationDrug Shortage Alert 8/1/2014
Headquarters 500 Midway Drive Mount Prospect, Illinois 60056-5811 USA Main Telephone +1 847 827-6869 Customer Service +1 847 827-6888 Facsimile +1 847 827-6886 Email info@sccm.org www.sccm.org Drug Shortage
More informationInotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS
Inotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS 1. Definition -an agent that affects the contractility of the heart -may be positive (increases contractility) or
More informationOpioid Analgesics. Week 19
Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,
More informationWho Should Participate*
earn 25 contact hours! For as little as $49. 95 Announcing: Sedation Clinical Competency Program Finally A practical solution to satisfy formal training, credentialing, and competency-based educational
More informationACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationPHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
More informationVeterinary Anesthetic and Analgesic Formulary 3 rd Edition, Version G
Veterinary Anesthetic and Analgesic Formulary 3 rd Edition, Version G I. Introduction and Use of the UC Denver Veterinary Formulary II. Anesthetic and Analgesic Considerations III. Species Specific Veterinary
More informationMississippi Board of Nursing
Mississippi Board of Nursing Regulating Nursing Practice www.msbn.state.ms.us 713 Pear Orchard Road, Suite 300 Ridgeland, MS 39157 Administration and Management of Intravenous (IV) Moderate Sedation POSITION
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationLidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD
Lidocaine Infusion for Perioperative Pain Management Marley Linder, PharmD Matt McEvoy, MD Perioperative Surgical Home: PCS Shared Goals Improved Outcomes (pain, PONV, LOS, SSI) Improve Throughput (Clinic
More informationCorporate Medical Policy
File Name: anesthesia_services Origination: 8/2007 Last CAP Review: 1/2016 Next CAP Review: 1/2017 Last Review: 1/2016 Corporate Medical Policy Description of Procedure or Service There are three main
More informationConscious Sedation Policy
PURPOSE Provide guidelines to ensure safe and consistent process for patient selection, administration, monitoring and discharge care of patients receiving conscious sedation. Conscious sedation refers
More informationThe American Society of Anesthesiologists (ASA) has defined MAC as:
Medical Coverage Policy Monitored Anesthesia Care (MAC) sad EFFECTIVE DATE: 09 01 2004 POLICY LAST UPDATED: 11 04 2014 OVERVIEW The intent of this policy is to address anesthesia services for diagnostic
More informationPhilip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates
More informationCardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008
Cardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008 Preamble Survival from cardiorespiratory arrest for patients who present with ventricular fibrillation
More informationCH CONSCIOUS SEDATION
Summary: CH CONSCIOUS SEDATION It is the policy of Carondelet Health that moderate conscious sedation of patients will be undertaken with appropriate evaluation and monitoring. Effective Date: 9/4/04 Revision
More informationGE Healthcare. Quick Guide PDF PROOF. Neuromuscular Transmission (NMT)
GE Healthcare Quick Guide Neuromuscular Transmission (NMT) WHAT is Neuromuscular Transmission (NMT)? Neuromuscular Transmission (NMT) is the transfer of an impulse between a nerve and a muscle in the neuromuscular
More informationCardiac Arrest Pediatric Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008
Cardiac Arrest Pediatric Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008 Preamble In contrast to cardiac arrest in adults, cardiopulmonary arrest in pediatric
More informationThe Difficult to Sedate ICU Patient
The Difficult to Sedate ICU Patient Dan Burkhardt, M.D. Associate Professor Department of Anesthesia and Perioperative Care University of California San Francisco burkhard@anesthesia.ucsf.edu Richmond
More informationCODING AND COMPLIANCE NEW APPOINTMENT AND REAPPOINTMENT MODULE FOR ANESTHESIA FACULTY
CODING AND COMPLIANCE NEW APPOINTMENT AND REAPPOINTMENT MODULE FOR ANESTHESIA FACULTY ANESTHESIA BILLING: MUST BE DOCUMENTED AS: Personally performed: you perform the case without a resident or a CRNA
More informationCenter for Medicaid and State Operations/Survey and Certification Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop S2-12-25 Baltimore, Maryland 21244-1850 Center for Medicaid and State Operations/Survey
More informationGuidelines for Spay/Neuter
Guidelines for Standards of Care in Animal Shelters Guidelines for Spay/Neuter Cynthia Barker Cox, DVM MSPCA Boston, MA Natalie Isaza, DVM College of Veterinary Medicine University of Florida Guidelines
More informationULTIVA - The analgesic System of Anesthesia
ULTIVA (remifentanil hydrochloride) for Injection Prescribing Information DESCRIPTION ULTIVA (remifentanil hydrochloride) for Injection is a μ-opioid agonist chemically designated as a 3-[4-methoxycarbonyl-4-[(1-oxopropyl)phenylamino]-1-
More informationYamaguchi University, Japan
Yamaguchi University, Japan The United Graduate School of Veterinary Science The Stress Related Neuroendocrine and Metabolic Effects of Alpha-2 Adrenergic Agents and Their Combinations with Injectable
More informationPain Management in the Critically ill Patient
Pain Management in the Critically ill Patient Jim Ducharme MD CM, FRCP President-Elect, IFEM Clinical Professor of Medicine, McMaster University Adjunct Professor of Family Medicine, Queens University
More informationUNMH Procedural Sedation Privileges
o Initial privileges (initial appointment) o Renewal of privileges (reappointment) o Expansion of privileges (modification) All new applicants must meet the following requirements as approved by the UNMH
More informationPain Management. Introduction
Pain Management Authors: David R Patterson PhD, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington; Helma Hoflund RN, SCRN, MScN, Queen Elizabeth Central
More informationProvider Sedation Education
Provider Sedation Education Purpose: To provide sedation education for IU Health physicians and dentists seeking moderate and deep sedation credentials. Credentialing requirements: Moderate sedation credentials:
More informationDEFINITIONS Minimal Sedation: Moderate Sedation/Analgesia: Deep Sedation/Analgesia: Anesthesia:
Policy: Conscious Sedation Owner: CNO, Anesthesia Department, Medical Staff Initiated: 08/2010 Version: 2 Last Approval Date: 8/2012 Reference: S. Smith, D. Duell, B. Martin, Clinical Nursing Skills, Basic
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationtable of contents drug reference
table of contents drug reference ADULT DRUG REFERENCE...155 161 PEDIATRIC DRUG REFERENCE...162 164 PEDIATRIC WEIGHT-BASED DOSING CHARTS...165 180 Adenosine...165 Amiodarone...166 Atropine...167 Defibrillation...168
More informationACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767 Copyright 2010 American Heart Association ACLS Cardiac Arrest Circular Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
More informationPREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
More informationUpdate on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new?
Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? DVM, DACVA Objective: Update on the new Small animal guidelines for CPR and a discussion of the 2012 Reassessment Campaign on
More informationCommunity Ambulance Service of Minot ALS Standing Orders Legend
Legend Indicates General Information and Guidelines Indicates Procedures Indicates Medication Administration Indicates Referral to Other Protocol Indicates Referral to Online Medical Direction Pediatric
More informationGRADUATE PROGRAM IN NURSE ANESTHESIA. Course Descriptions and Student Learning Objectives
GRADUATE PROGRAM IN NURSE ANESTHESIA Course Descriptions and NA640 Chemistry & Physics for Nurse Anesthesia - 4 Credits This course examines the principles of inorganic chemistry, organic chemistry, biochemistry
More informationMilwaukee School of Engineering Gerrits@msoe.edu. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
More informationAdministrative Manual
I. Description Administrative Manual Policy Name Pediatric Sedation Policy For Non- Anesthesiologists Policy Number ADMIN 0212 Date this Version Effective March 1, 2011 Responsible for Content Pediatric
More informationNaloxone Hydrochloride Injection, USP Opioid Antagonist
Naloxone Hydrochloride Injection, USP Opioid Antagonist Rx Only DESCRIPTION Naloxone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone. In structure it differs from oxymorphone
More informationCardiac Arrest VF/Pulseless VT Learning Station Checklist
Cardiac Arrest VF/Pulseless VT Learning Station Checklist VF/VT 00 American Heart Association Adult Cardiac Arrest Shout for Help/Activate Emergency Response Epinephrine every - min Amiodarone Start CPR
More informationOptions for Managing Colic Pain. Hagyard Equine Medical Institute s Pain Management Seminar October 2009
Options for Managing Colic Pain Hagyard Equine Medical Institute s Pain Management Seminar October 2009 Introduction Guest Speaker: Eric J. Abrahamsen, DVM, DACVA Ocala Equine Hospital 10855 NW US Hwy
More informationCommon Ventilator Management Issues
Common Ventilator Management Issues William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center You have just admitted a 28 year-old
More informationACLS PRE-TEST ANNOTATED ANSWER KEY
ACLS PRE-TEST ANNOTATED ANSWER KEY June, 2011 Question 1: Question 2: There is no pulse with this rhythm. Question 3: Question 4: Question 5: Question 6: Question 7: Question 8: Question 9: Question 10:
More informationDISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE
REFERENCES: The Joint Commission Accreditation Manual for Hospitals American Society of Post Anesthesia Nurses: Standards of Post Anesthesia Nursing Practice (1991, 2002). RELATED DOCUMENTS: SHC Administrative
More informationThe ASA defines anesthesiology as the practice of medicine dealing with but not limited to:
1570 Midway Pl. Menasha, WI 54952 920-720-1300 Procedure 1205- Anesthesia Lines of Business: All Purpose: This guideline describes Network Health s reimbursement of anesthesia services. Procedure: Anesthesia
More informationNurses Self Paced Learning Module on Pain Management
Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa
More informationMODERATE SEDATION RECORD (formerly termed Conscious Sedation)
(POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz
More informationLyon Lee DVM PhD DACVA
Introduction EQUINE ANESTHESIA Lyon Lee DVM PhD DACVA Higher morbidity and mortality associated with general anesthesia (1:100) in comparison to small animals (1:1000) or human (1: 200,000) No change of
More informationMALIGNANT HYPERTHERMIA, ANESTHESIA, AND DEXMEDETOMIDINE: A SAFE ALTERNATIVE IN THREE CHALLENGING PATIENTS
MALIGNANT HYPERTHERMIA, ANESTHESIA, AND DEXMEDETOMIDINE: A SAFE ALTERNATIVE IN THREE CHALLENGING PATIENTS Richard D. Urman, M.D. Instructor in Anesthesia Harvard Medical School Department of Anesthesiology,
More informationVA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA
GUIDELINES FOR PATIENT-CONTROLLED ANALGESIA (PCA) AND PATIENT- CONTROLLED EPIDURAL ANALGESIA (PCEA) FOR ACUTE PAIN MANAGEMENT 1. PURPOSE: To assure the safe and effective use of patient controlled analgesia
More informationGlycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Solution for Injection
NEW ZEALAND DATA SHEET Glycopyrronium Bromide 0.5mg/mL and Neostigmine Metilsulfate 2.5mg/mL Solution for Injection Each 1mL contains Glycopyrrolate USP 0.5mg (Glycopyrronium Bromide) and Neostigmine Metilsulfate
More informationEndotracheal intubation is performed with the use of
CLINICAL Rapid Sequence Induction Medications: An Update Author: Michael A. Frakes, RN, BSN, CFRN, CCRN, EMTP, Hartford, Conn Michael A. Frakes is Flight Nurse, LIFE STAR/Hartford Hospital, Hartford, Conn.
More informationGuidelines for the Use of Naloxone in Palliative Care in Adult Patients
Guidelines for the Use of Naloxone in Palliative Care in Adult Patients Date Approved by Network Governance May 2012 Date for Review May 2015 Changes between Version 1 and 2 1. Guideline background 2.
More informationNaloxone treatment of opioid overdose
Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing
More informationPACT Module Sedation. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT Module Sedation Intensive Care Training Program Radboud University Medical Centre Nijmegen Important concepts Prolonged use of sedatives associated with significant side effects - drug holiday & sedation
More informationA HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES. Donald R Jasinski, MD
A HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES Donald R Jasinski, MD Origin of methods Modify morphine molecule Develop a selective analgesic lacking abuse potential Reduce public health and
More informationSutter Health: Sacramento-Sierra REGIONAL ICU DELIRIUM PROTOCOL
Sutter Health: Sacramento-Sierra REGIONAL ICU DELIRIUM PROTOCOL Delirium-(acute brain dysfunction) is defined as a disturbance of consciousness with inattention accompanied by a change in cognition or
More informationMaking our pets comfortable. A modern approach to pain and analgesia.
Making our pets comfortable. A modern approach to pain and analgesia. What is pain? Pain is an unpleasant sensory and emotional experience with awareness by an animal to damage or potential damage to its
More informationWithdrawal symptoms in long term sedation exposure of pediatric intensive care patients
CLINICAL PRACTICE Withdrawal symptoms in long term sedation exposure of pediatric intensive care patients Susanne Kotz University Medical Center Hamburg-Eppendorf, Germany Correspondence: Susanne Kotz.
More informationOverview. Geriatric Overview. Chapter 26. Geriatrics 9/11/2012
Chapter 26 Geriatrics Slide 1 Overview Trauma Common Medical Emergencies Special Considerations in the Elderly Medication Considerations Abuse and Neglect Expanding the Role of EMS Slide 2 Geriatric Overview
More informationTarget groups: Paramedics, nurses, respiratory therapists, physicians, and others who manage respiratory emergencies.
Overview Estimated scenario time: 10 15 minutes Estimated debriefing time: 10 minutes Target groups: Paramedics, nurses, respiratory therapists, physicians, and others who manage respiratory emergencies.
More informationInfluence of ph Most local anesthetics are weak bases.
Local anesthetics The agent must depress nerve conduction. The agent must have both lipophilic and hydrophilic properties to be effective by parenteral injection. Structure-activity relationships The typical
More informationBier Block (Intravenous Regional Anesthesia)
Bier Block (Intravenous Regional Anesthesia) History August Bier introduced this block in 1908. Early methods included the use of two separate tourniquets and procaine was the local anesthetic of choice.
More informationOpioid toxicity and alternative opioids. Palliative care fixed resource session
Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher
More informationCase Study: General Anesthesia for acute appendectomy in a pregnant woman. David Roy Godden. Clinical Residency in Nurse Anesthesia II ANST 507
Case Study: General Anesthesia for acute appendectomy in a pregnant woman By David Roy Godden Clinical Residency in Nurse Anesthesia II ANST 507 Michele E. Gold, CRNA, PhD Associate Professor of Clinical
More information1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
More informationPhysiology and Pharmacology
Pharmacokinetics Physiology and Pharmacology Pharmacokinetics of Local Anesthetics Uptake Oral Route Topical Route Injection Distribution Metabolism (Biotransformation) Excretion Uptake So what? Vasoactivity
More information